Furthermore, an additional study revealed that fluoxetine hinders lung cancer progression through activation of the ATF4-AKT-mTOR signaling pathway, inducing cell cycle arrest and autophagy to impede cancer cell proliferation without affecting normal lung epithelial cell proliferation (46). This evidence concerns the gene AKT1 and lung carcinoma.